» Articles » PMID: 24899524

Disruption of Heterotypic Community Development by Porphyromonas Gingivalis with Small Molecule Inhibitors

Overview
Specialties Dentistry
Microbiology
Date 2014 Jun 6
PMID 24899524
Citations 17
Authors
Affiliations
Soon will be listed here.
Abstract

Porphyromonas gingivalis is one of the main etiological organisms in periodontal disease. On oral surfaces P. gingivalis is a component of multispecies biofilm communities and can modify the pathogenic potential of the community as a whole. Accumulation of P. gingivalis in communities is facilitated by interspecies binding and communication with the antecedent colonizer Streptococcus gordonii. In this study we screened a library of small molecules to identify structures that could serve as lead compounds for the development of inhibitors of P. gingivalis community development. Three small molecules were identified that effectively inhibited accumulation of P. gingivalis on a substratum of S. gordonii. The structures of the small molecules are derived from the marine alkaloids oroidin and bromoageliferin and contain a 2-aminoimidazole or 2-aminobenzimidazole moiety. The most active compounds reduced expression of mfa1 and fimA in P. gingivalis, genes encoding the minor and major fimbrial subunits, respectively. These fimbrial adhesins are necessary for P. gingivalis co-adhesion with S. gordonii. These results demonstrate the potential for a small molecular inhibitor-based approach to the prevention of diseases associated with P. gingivalis.

Citing Articles

The Application of Small Molecules to the Control of Typical Species Associated With Oral Infectious Diseases.

Yang S, Lyu X, Zhang J, Shui Y, Yang R, Xu X Front Cell Infect Microbiol. 2022; 12:816386.

PMID: 35265531 PMC: 8899129. DOI: 10.3389/fcimb.2022.816386.


: where do we stand in our battle against this oral pathogen?.

Howard K, Gonzalez O, Garneau-Tsodikova S RSC Med Chem. 2021; 12(5):666-704.

PMID: 34124669 PMC: 8152699. DOI: 10.1039/d0md00424c.


Porphyromonas gingivalis fimbrial protein Mfa5 contains a von Willebrand factor domain and an intramolecular isopeptide.

Heidler T, Ernits K, Ziolkowska A, Claesson R, Persson K Commun Biol. 2021; 4(1):106.

PMID: 33495563 PMC: 7835359. DOI: 10.1038/s42003-020-01621-w.


Natural products as inspiration for the development of bacterial antibiofilm agents.

Melander R, Basak A, Melander C Nat Prod Rep. 2020; 37(11):1454-1477.

PMID: 32608431 PMC: 7677205. DOI: 10.1039/d0np00022a.


In Vitro and In Vivo Assessment of the Efficacy of Bromoageliferin, an Alkaloid Isolated from the Sponge , against .

Pech-Puch D, Perez-Povedano M, Martinez-Guitian M, Lasarte-Monterrubio C, Vazquez-Ucha J, Bou G Mar Drugs. 2020; 18(6).

PMID: 32585891 PMC: 7345159. DOI: 10.3390/md18060326.


References
1.
Rogers S, Melander C . Construction and screening of a 2-aminoimidazole library identifies a small molecule capable of inhibiting and dispersing bacterial biofilms across order, class, and phylum. Angew Chem Int Ed Engl. 2008; 47(28):5229-31. DOI: 10.1002/anie.200800862. View

2.
Socransky S, Manganiello A, Propas D, ORAM V, van Houte J . Bacteriological studies of developing supragingival dental plaque. J Periodontal Res. 1977; 12(2):90-106. DOI: 10.1111/j.1600-0765.1977.tb00112.x. View

3.
Kuboniwa M, Amano A, Hashino E, Yamamoto Y, Inaba H, Hamada N . Distinct roles of long/short fimbriae and gingipains in homotypic biofilm development by Porphyromonas gingivalis. BMC Microbiol. 2009; 9:105. PMC: 2697998. DOI: 10.1186/1471-2180-9-105. View

4.
Kuboniwa M, Tribble G, James C, Kilic A, Tao L, Herzberg M . Streptococcus gordonii utilizes several distinct gene functions to recruit Porphyromonas gingivalis into a mixed community. Mol Microbiol. 2006; 60(1):121-39. DOI: 10.1111/j.1365-2958.2006.05099.x. View

5.
Rickard A, Palmer Jr R, Blehert D, Campagna S, Semmelhack M, Egland P . Autoinducer 2: a concentration-dependent signal for mutualistic bacterial biofilm growth. Mol Microbiol. 2006; 60(6):1446-56. DOI: 10.1111/j.1365-2958.2006.05202.x. View